Navigation Links
Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology
Date:2/20/2008

herein are the property of their respective owners.

This news release contains forward-looking statements regarding SGI technologies and third-party technologies that are subject to risks and uncertainties. These risks and uncertainties could cause actual results to differ materially from those described in such statements. The reader is cautioned not to rely unduly on these forward-looking statements, which are not a guarantee of future or current performance. Such risks and uncertainties include long-term program commitments, the performance of third parties, the sustained performance of current and future products, financing risks, the ability to integrate and support a complex technology solution involving multiple providers and users, and other risks detailed from time to time in the company's most recent SEC reports, including its reports on Form 10-K and Form 10-Q.

MEDIA CONTACT

Marla Robinson

marlar@sgi.com

256.773.2371

SGI PR HOTLINE

650.933.7777

SGI PR FACSIMILE

650.933.0714


'/>"/>
SOURCE SGI
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Imaging Diagnostic Systems New Laser Breast Imaging Scanner Introduced in Malaysia
2. BioElectronics Corporation Announces Singapore and Malaysia Sales
3. Biopure Gives Update on Malaysia Joint Venture Discussions
4. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
5. Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2007 Financial Results
6. Human Genome Sciences and Xencor Announce Antibody Collaboration
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
8. Venter Institute Scientists Create First Synthetic Bacterial Genome
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
10. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
11. Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a primary commercial focus on ... has been granted a Type C meeting with the ... meeting will be held in February 2015.  During this ...
(Date:12/15/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology,  today celebrated continued ... its exVive3D TM Human Liver Tissue.  The ... commercial release on November 18, has been recognized ... awards for innovation. Most recently, on ...
(Date:12/13/2014)... , Dec. 12, 2014 /CNW/ - MaRS and Virgin ... today that they have joined forces to support Canadian entrepreneurs ... , Virgin Group Founder was at the MaRS Centre to ... new, national impact venture fund. This fund has $1 million ... Vancouver -based Mindset Social Innovation Foundation, founded ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
... , For low-throughput disruption of a wide range of biological ... , , ... a variety of biological samples, including animal,and human tissues and cells and plant tissue. , ... The TissueRuptor system provides: , ...
... , , ... biological sample becomes extremely unstable upon collection of the sample, ... expression analysis in applications such as real-time RT-PCR and microarray ... products which enable stabilization and purification of,high-quality RNA from animal ...
... An air impaction microbial assessment of your ... system , RUDY ... Manufacturers of medical devices who ... Applications include injection molding, operation of conveyor belts, and/or aseptic cleaning processes. ...
Cached Biology Technology:TissueRuptor System 2TissueRuptor System 3Successful stabilization of gene expression profiles 2Successful stabilization of gene expression profiles 3Testing Compressed Air Lines for Microbiological Contamination 2Testing Compressed Air Lines for Microbiological Contamination 3Testing Compressed Air Lines for Microbiological Contamination 4Testing Compressed Air Lines for Microbiological Contamination 5Testing Compressed Air Lines for Microbiological Contamination 6
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
(Date:12/10/2014)... Dec. 9, 2014  Wake Forest Baptist Medical Center today ... its School of Medicine. Funding for this $50 million ... that will be publicly launched next summer. ... the former 60 series R.J. Reynolds Tobacco Company complex, ... will begin immediately with plans to be ready to ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... NC ,Outer, tree canopy leaves influence the sunlight reaching inner ... The shape and physiology of leaves within the tree ... position within the tree crown. This phenomenon is expected to ... use resources. A new study describes how the ...
... with a tiny groove carved in it, a team ... Technology (NIST) and the Polytechnic Institute of New York ... making biodegradable polymers. Their recently published work* is a ... more commonly associated with inkjet printers and medical diagnostics, ...
... strain of E. coli bacteria could help treat an reduce ... be associated with Crohn,s disease. Researchrs from the University ... 2011 issue of the journal Applied and Environmental Microbiology. ... gastrointestinal tract and is believed to develop as a result ...
Cached Biology News:Microreactors: Small scale chemistry could lead to big improvements for biodegradable polymers 2